Acute pancreatitis and the role of histamine-2 receptor antagonists: A meta-analysis of randomized controlled trials of cimetidine

European Journal of Gastroenterology and Hepatology

Volumn 14, Issue 6, 2002, Pages 679-686

  Morimoto, Takeshi ^a   Noguchi, Yoshinori ^a   Sakai, Tatsuya ^a   Shimbo, Takuro ^a   Fukui, Tsuguya ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cimetidine; Histamine H2 antagonists; Meta analysis; Pancreatitis

Indexed keywords

CIMETIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; PLACEBO;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENDOCRINE FUNCTION; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PANCREAS JUICE; PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; STOMACH ACID SECRETION; STOMACH PH;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; CIMETIDINE; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PANCREATITIS; RANDOMIZED CONTROLLED TRIALS;

EID: 0036088705     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200206000-00014     Document Type: Article

References (57)

1. Acute pancreatitis
2. Acute pancreatitis
3. Emergency drug therapy of acute pancreatitis
4. Pancreatitis
5. Acute pancreatitis
6. United Kingdom guidelines for the management of acute pancreatitis
7. Suspected cimetidine-induced acute pancreatitis
8. Drug-induced pancreatitis
9. Drug-associated acute pancreatitis: Twenty-one years of spontaneous reporting in the Netherlands
10. The risk of acute pancreatitis associated with acid-suppressing drugs
11. Prospective, randomized trial of nasogastric suction in patients with acute pancreatitis
12. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11 through 13, 1992
13. Statistical aspects of the analysis of data from retrospective studies of disease
14. Meta-analysis in clinical trials
15. The combination of estimates from different experiments
16. A prospective study of the antisecretory and therapeutic effects of cimetidine and glucagon in human acute pancreatitis
17. A randomized trial comparing cimetidine to nasogastric suction in acute pancreatitis
18. Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency
19. No effects of cimetidine on the therapeutic response to oral enzymes in severe pancreatic insufficiency
20. Reflections on the use of cimetidine in acute pancreatitis
21. Pancreatic resection versus peritoneal lavation for acute fulminant pancreatitis. A randomized prospective study
22. Therapy of pancreatogenic steatorrhoea: Does acid protection of pancreatic enzymes offer any advantage?
23. Pancreatic enzyme replacement therapy. Importance of gastric acid secretion, H2-antagonists, and enteric coating
24. Prospective randomized study comparing three surgical techniques for the treatment of gastric outlet obstruction secondary to duodenal ulcer
25. Cimetidine in the treatment of acute alcoholic pancreatitis. A randomized, double-blind study
26. Controlled trial of cimetidine in acute pancreatitis
27. A clinical trial of cimetidine in acute pancreatitis
28. Treatment of acute alcoholic pancreatitis: The roles of cimetidine and nasogastric suction
29. Comparison of fasting, nasogastric suction and cimetidine in the treatment of acute pancreatitis
30. Morbidity and mortality in 602 patients with acute pancreatitis seen between the years 1980-1994
31. High early mortality rate from acute pancreatitis in Scotland, 1984-1995
32. Cimetidine treatment in acute experimental pancreatitis
33. Cimetidine: Harmful in acute experimental pancreatitis?
34. Medical management of acute pancreatitis
35. Metiamide, an H2-receptor blocker, as inhibitor of basal and meal-stimulated gastric acid secretion in patients with duodenal ulcer
36. Aspects of the effect of metiamide on pentagastrin-stimulated and basal gastric secretion of acid and pepsin in man
37. Effects of cimetidine and poldine on nocturnal gastric secretion in duodenal ulcer
38. Effect of histamine on pancreatic exocrine secretion in the dog
39. Effect of cimetidine on pancreatic exocrine secretion
40. Effect of histamine-H2-receptor antagonists on the exocrine pancreatic secretion
41. Cimetidine: Effect on pancreatic and biliary function in man
42. Histamine H2-receptor agonists and antagonists on pancreatic exocrine secretion of the dog
43. Cimetidine increases the pancreatic response to histamine
44. Variation in annual incidence of primary acute pancreatitis in Nottingham, 1969-74
45. Etiology and incidence of acute pancreatitis: A 20-year study in a single institution
46. Relation of diagnostic serum amylase levels to aetiology and severity of acute pancreatitis
47. Incidence, aetiology and mortality rate of acute pancreatitis over 10 years in a defined urban population in Sweden
48. Extensive aetiological investigations in acute pancreatitis: Results of a 1-year prospective study
49. A prospective audit against national standards of the presentation and management of acute pancreatitis in the South of England
50. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis
51. Severe acute pancreatitis: Prognostic factors in 270 consecutive patients
52. Results of treatment in severe acute pancreatitis
53. Short and long term outcome of severe acute pancreatitis
54. Pancreatic necrosis: Assessment of outcome related to quality of life and cost of management
55. Acute pancreatitis: The substantial human and financial costs